A balanced guide for patients and clinicians

Voriconazole is a broad-spectrum triazole antifungal used in:
  • Chronic pulmonary aspergillosis (CPA)

  • Allergic bronchopulmonary aspergillosis (ABPA) (selected cases)

  • Invasive aspergillosis

  • Azole-resistant or itraconazole-intolerant cases

It is available orally and intravenously and is often used when a stronger or more reliably absorbed azole is required.


1️⃣ What Voriconazole Does

Voriconazole works by blocking fungal ergosterol synthesis (CYP51 inhibition), which disrupts the fungal cell membrane.

Compared with itraconazole:

  • More potent against Aspergillus

  • More predictable oral absorption

  • More central nervous system penetration

It often produces symptom improvement over weeks, though some effects (e.g. visual symptoms) may occur quickly.


2️⃣ How Long Is Treatment?

In CPA

  • Often 6–12 months or longer

  • Sometimes used as second-line or after intolerance to itraconazole

  • Long-term suppressive therapy may be required

In ABPA

  • Used in selected steroid-dependent or refractory cases

In invasive disease

  • Typically several months depending on response and immune status


3️⃣ Why Blood Level Monitoring Is Essential

Voriconazole has non-linear pharmacokinetics.

Small dose changes can cause large blood level shifts.

Two patients on the same dose may have very different levels due to:

  • Liver metabolism (CYP2C19 genetic variation is important)

  • Drug interactions

  • Age

  • Weight

  • Liver function


If Levels Are Too Low

  • Treatment failure

  • Persistent fungal activity

  • Risk of resistance


If Levels Are Too High

  • Liver toxicity

  • Neurological side effects

  • Visual disturbances

  • Increased interaction risk


Typical Target (Trough)

  • Generally 1–5.5 mg/L (lab dependent)

  • Toxicity risk increases >5–6 mg/L

Levels are usually checked:

  • 5–7 days after starting

  • After dose adjustments

  • If side effects occur

  • If clinical response is inadequate


4️⃣ Common Side Effects (Often Mild & Reversible)

Visual Disturbances (Very Common but Usually Harmless)

  • Blurred vision

  • Altered colour perception

  • Light sensitivity

  • “Wavy” vision

These typically:

  • Occur within 30–60 minutes of dosing

  • Last less than an hour

  • Reduce over time

Patients should avoid night driving initially until they understand their response.


Photosensitivity

  • Increased sensitivity to sunlight

  • Sunburn risk

  • Long-term risk of skin damage with prolonged therapy

Sun protection is important.


Gastrointestinal

  • Nausea

  • Abdominal discomfort


5️⃣ Less Common but Important Effects

Neurological

  • Headache

  • Vivid dreams

  • Hallucinations (usually at high levels)

  • Confusion (dose-related)

These are generally reversible with dose adjustment.


Liver Abnormalities

Routine liver function monitoring is required.

Most abnormalities are mild and resolve with dose modification.


Cardiac Effects

Voriconazole can prolong the QT interval.

Caution in patients with:

  • Known arrhythmias

  • Electrolyte imbalance

  • Other QT-prolonging drugs

ECG monitoring may be appropriate in higher-risk patients.


Skin Cancer Risk (Long-Term Use)

With prolonged use (especially >1–2 years):

  • Increased risk of skin squamous cell carcinoma

  • Particularly in transplant recipients

Sun protection and dermatology review are advised for long-term therapy.


6️⃣ Food & Drug Advice

  • Avoid grapefruit

  • Avoid St John’s Wort

  • Take tablets at least 1 hour before or after meals (food reduces absorption)

Voriconazole has many CYP-mediated interactions and requires careful medication review.


7️⃣ Comparison With Itraconazole (Simple Overview)

Feature Itraconazole Voriconazole
Absorption variability High More predictable
Visual side effects Rare Common but mild
Photosensitivity Rare More common
QT prolongation Minimal Possible
TDM needed Yes Yes (essential)

Balanced Summary for Patients

Voriconazole is a strong antifungal used when more reliable or potent treatment is needed. Most side effects are manageable and reversible, and blood monitoring keeps treatment safe.


Clinician Checklist

  • Confirm indication and prior azole exposure

  • Check baseline LFTs

  • Review ECG if cardiac risk present

  • Assess drug interactions (CYP2C19, 2C9, 3A4)

  • Arrange trough level at day 5–7

  • Counsel regarding visual symptoms and sun protection

Path: Start » Treatment » Antifungals » Voriconazole in Aspergillosis

Latest News posts